Clinical Trials Logo

Filter by:
NCT ID: NCT01513109 Recruiting - Clinical trials for Acute Myelogenous Leukemia

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

ASCI
Start date: December 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and the efficacy of combined treatment strategy of WT1ASCI, infusion of ex vivo regulatory T cells depleted T lymphocytes and in vivo regulatory T cells depletion as post-consolidation therapy in patients with WT1-positive Acute Myeloid Leukemia. The study will also evaluate the clinical activity and immune response of this approach in bad risk patients in CR1 and all patients in CR2 or CR3, non eligible for an allogeneic Hematopoietic Stem Cell Transplantation

NCT ID: NCT01509027 Recruiting - Clinical trials for Chronic Kidney Disease

Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients

Start date: January 2012
Phase: N/A
Study type: Interventional

Hyperphosphatemia is a common and severe complication in chronic kidney disease patients treated with hemodialysis. A phosphate restricted diet and oral phosphate binders are the cornerstones in the prevention and treatment of this complication. However, noncompliance is an prevalent problem resulting in poorly controled hyperphosphatemia in a substantial proportion of hemodialysis patients. The present study aims at identifying risk factors for non compliance and also test the hypothesis that compliance can be improved by education patients on the consequences of hyperphosphatemia and the importance of diet and phosphate binder therapy.

NCT ID: NCT01499329 Recruiting - Clinical trials for Peripheral Artery Disease

Safety and Performance of the Zeus CC Stent for the Treatment of Iliac Occlusive Disease

EAZY
Start date: December 2011
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate safety and performance of the balloon-expandable Zeus CC (Rontis AG) stent for the treatment of Trans-Atlantic Inter-Society Consensus (TASC) A, B, C and D iliac lesions.

NCT ID: NCT01432782 Recruiting - Clinical trials for Esophageal Spasm, Diffuse

Botulinum Toxin Injection to Treat Diffuse Esophageal Spasm

Botox
Start date: February 2010
Phase: N/A
Study type: Interventional

This study evaluates the effect of botulinum toxin 100 U or saline, injected endoscopically in the distal esophagus, on symptoms and manometry pattern in patients with diffuse esophageal spasm.

NCT ID: NCT01428323 Recruiting - Clinical trials for Aerosol Drug Therapy

Study of the Aerosol Deposition With Vented and Unvented Jet Nebulizer in Healthy Subjets

Start date: January 2011
Phase: N/A
Study type: Interventional

Open-vent jet nebulizers are frequently used to promote drug lung deposition but their clinical efficacy and indications are not clear. Our study aimed to compare inhaled mass, and lung deposition of amikacin by using a jet nebulizer (Sidestream) under two different configurations: vented and unvented coupled to a 110 ml corrugated piece of tubing.

NCT ID: NCT01420562 Recruiting - Clinical trials for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis

Start date: September 2011
Phase: N/A
Study type: Observational

The goal of this study is to calculate pharmacokinetic parameters and to evaluate the trough levels of posaconazole reached in patients with different stages of mucositis, due to chemotherapy and total body irradiation.

NCT ID: NCT01413373 Recruiting - Malocclusion Clinical Trials

3D Craniofacial Cephalometric Analysis

ACRO3D
Start date: August 2008
Phase:
Study type: Observational

Development of three-dimensional craniofacial cephalometric analysis for virtual planning in orthognathic surgery.

NCT ID: NCT01402037 Recruiting - Type 1 Diabetes Clinical Trials

Beta Cell Function in (Pre)Type 1 Diabetes

Start date: July 2011
Phase: N/A
Study type: Interventional

Increased glycemic variability has been proposed as an independent predictor of hypoglycemia in diabetic patients. Likewise, episodes of dysglycemia have been found to be predictive of diabetes in antibodypositive nondiabetic individuals. We hypothesise that an in-depth observational study comparing state-of-the-art measures of functional beta cell mass and glycemic variability will specify the relationship between both variables over a broad range of residual function and will identify treatment goals for functional beta cell mass to be reached in future beta cell therapy trials in order to avoid frequent hypoglycemia in patients and dysglycemia in risk groups. The available expertise and infrastructure (see background and (inter)national context) place the promoters of the present project in a unique position to carry out the planned experiments and support their feasibility.

NCT ID: NCT01399528 Recruiting - Epilepsy Clinical Trials

A Pharmacogenomic Exploration of Lacosamide Response

Start date: September 2011
Phase: N/A
Study type: Observational

This is an observational study exploring the genetics of lacosamide response. The study will last 3 years and has been divided in to three stages; 1) recruitment, 2) observational phase, 3) genotyping and analysis. Patients initiating lacosamide are recruited and their baseline seizure frequency is assessed retrospectively. Patients are then monitored for 18 months with an assessment (via interview and where possible seizure diaries) of seizure frequency and other treatment related phenotypes every 3 months. The recruitment period will span months 1-12, the observational period will span months 1-30 and analysis of data will be conducted between months 30-36 (see Figure 2 below). Target sample size is 610. Primary objective: To determine the clinical relevance of genetic variation in predicting lacosamide responsive and non-responsive patients. Secondary objectives: To determine the clinical relevance of genetic variation in predicting: - Optimal dose of lacosamide - Adverse drug reactions to lacosamide

NCT ID: NCT01398917 Recruiting - Clinical trials for Primary Sclerosing Cholangitis

Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis

Start date: May 2011
Phase: Phase 3
Study type: Interventional

Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the biliary tract of unknown origin. Around 50% of patients develop during their disease course narrowing of the main bile duct with corresponding increase in symptoms such as itching, jaundice and abdominal pain. These narrowings can be treated by balloon dilatation or temporary insertion of a plastic endoprosthesis. However, it is not known which of these two therapeutic modalities is best. This study aims to compare both techniques in order to determine which is best in terms of postponing recurrence of the narrowing, safety and costs.